Human Lung Fibroblasts IMR-90 Transfection Kit
| Kit size Volume | Quantity | ||
|---|---|---|---|
| 1.5 ml CRISPR(Cat-216064) | Inquiry | Add to cart | |
| 0.5 ml(Cat-683062) | Inquiry | Add to cart | |
| 1.5 ml(Cat-683163) | Inquiry | Add to cart | |
| 8.0 ml(Cat-683265) | Inquiry | Add to cart |
Description
Product Information
Modes of administration
Reagent exhibits at least 91% transfection efficiency of siRNA delivery. Transfection efficiency was determined by qRT-PCR.
Description
In 1975, W.W. Nichols and his team created the IMR-90 cell line using lung fibroblasts from a 16-week-old Caucasian female fetus. This cell line is suitable for many molecular biology-related studies as a host for transfection experiments. The IMR-90 cell line exhibits features of both fibroblasts and differentiated smooth muscle cells and can divide approximately 58 times before it begins to age and cease replicating. These cells are commonly used as a model for fibroblast research and show characteristics similar to those of smooth muscle cells, such as elongated form and actin-attachment sites aligned longitudinally. To improve research efficiency, CD BioSciences offers a transfection reagent kit specially designed for this cell line.
